Anika Therapeutics (ANIK) Raw Materials (2011 - 2018)

Anika Therapeutics (ANIK) has 8 years of Raw Materials data on file, last reported at $13.2 million in Q3 2018.

• Raw Materials for Q3 2018 came in at $13.2 million, up 68.31% year-over-year; the trailing twelve-month figure through Sep 2018 was $13.2 million (up 68.31% YoY), and the FY2017 annual result was $11.3 million, up 91.98% from the prior year.
• Raw Materials climbed to $13.2 million in Q3 2018 per ANIK's latest filing, from $12.6 million in the prior quarter.
• Over five years, Raw Materials peaked at $13.2 million in Q3 2018 and troughed at $4.9 million in Q3 2015.
• A 5-year average of $7.4 million and a median of $6.3 million in 2017 frame the typical range for Raw Materials.
• The sharpest annual moves came in 2015 and 2018: Raw Materials dropped 28.96% in 2015, then surged 100.13% in 2018.
• A 5-year view of Raw Materials shows it stood at $6.2 million in 2014, then dropped by 6.2% to $5.8 million in 2015, then gained by 1.8% to $5.9 million in 2016, then soared by 91.98% to $11.3 million in 2017, then increased by 17.22% to $13.2 million in 2018.
• Business Quant data shows ANIK's Raw Materials at $13.2 million in Q3 2018, $12.6 million in Q2 2018, and $10.1 million in Q1 2018.